Lind Global Fund II LP 13D and 13G filings for TransCode Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 8:12 pm Sale | 2023-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | Lind Global Fund II LP | 796 0.100% | -1,098 (-57.95%) | Filing |
| 2023-12-07 4:30 pm Purchase | 2023-12-04 | 13G | TransCode Therapeutics, Inc. RNAZ | Lind Global Fund II LP | 1,894 9.900% | 1,894 (New Position) | Filing |